(Q42426925)

31 October 2017

0 references

NAFLD as a risk factor for HCC: new rules of engagement? (English)

1 reference

31 October 2017

0 references

hepatocellular carcinoma

1 reference

Ryota Masuzaki

1

1 reference

31 October 2017

Seth J Karp

series ordinal

2

1 reference

31 October 2017

Masao Omata

series ordinal

3

1 reference

31 October 2017

5 May 2016

1 reference

31 October 2017

Hepatology international

1 reference

31 October 2017

10

1 reference

31 October 2017

4

1 reference

31 October 2017

533-534

1 reference

Creative Commons Attribution 4.0 International

31 October 2017

start time

5 May 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s12072-016-9731-8

0 references

cites work

Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939149

Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939149

Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939149

Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939149

Long-term follow-up of patients with NAFLD and elevated liver enzymes

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939149

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939149

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939149

Hepatitis C in the United States

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939149

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939149

Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4939149

Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27146835

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12072-016-9731-8

1 reference

31 October 2017

1 reference

31 October 2017

PubMed publication ID

27146835

1 reference